A detailed history of Mariner, LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Mariner, LLC holds 10,625 shares of APLS stock, worth $357,637. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,625
Previous 11,775 9.77%
Holding current value
$357,637
Previous $451,000 32.15%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$28.84 - $41.15 $33,166 - $47,322
-1,150 Reduced 9.77%
10,625 $306,000
Q2 2024

Aug 13, 2024

SELL
$38.07 - $59.71 $98,601 - $154,648
-2,590 Reduced 18.03%
11,775 $451,000
Q1 2024

May 15, 2024

BUY
$55.39 - $72.47 $25,700 - $33,626
464 Added 3.34%
14,365 $844,000
Q4 2023

Feb 14, 2024

BUY
$37.14 - $64.82 $128,504 - $224,277
3,460 Added 33.14%
13,901 $832,000
Q3 2023

Nov 13, 2023

BUY
$23.65 - $89.22 $115,459 - $435,572
4,882 Added 87.82%
10,441 $397,000
Q2 2023

Aug 11, 2023

BUY
$76.68 - $93.31 $38,416 - $46,748
501 Added 9.91%
5,559 $506,000
Q1 2023

May 12, 2023

BUY
$46.59 - $66.96 $235,652 - $338,683
5,058 New
5,058 $334,000

Others Institutions Holding APLS

About Apellis Pharmaceuticals, Inc.


  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $3.7B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track Mariner, LLC Portfolio

Follow Mariner, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.